Faculty Opinions recommendation of Preoperative chemotherapy and radiotherapy concomitant to cetuximab in resectable stage IIIB NSCLC: a multicentre phase 2 trial (SAKK 16/08).

2019 ◽  
Author(s):  
Paul Van Schil
Keyword(s):  
Preoperative Chemotherapy ◽  
Stage Iiib ◽  
Phase 2 ◽  
Multicentre Phase ◽  
Phase 2 Trial

scholarly journals Preoperative chemotherapy and radiotherapy concomitant to cetuximab in resectable stage IIIB NSCLC: a multicentre phase 2 trial (SAKK 16/08)

2019 ◽  
Vol 120 (10) ◽  
pp. 968-974 ◽  
Author(s):  
Alessandra Curioni-Fontecedro ◽  
◽  
Jean Yannis Perentes ◽  
Hans Gelpke ◽  
Alexandros Xyrafas ◽  
...  
Keyword(s):  
Preoperative Chemotherapy ◽  
Stage Iiib ◽  
Phase 2 ◽  
Multicentre Phase ◽  
Phase 2 Trial

Low-dose dasatinib in older patients with chronic myeloid leukaemia in chronic phase (DAVLEC): a single-arm, multicentre, phase 2 trial

2021 ◽  
Vol 8 (12) ◽  
pp. e902-e911 ◽  
Author(s):  
Kazunori Murai ◽  
Hiroshi Ureshino ◽  
Takashi Kumagai ◽  
Hideo Tanaka ◽  
Kaichi Nishiwaki ◽  
...  
Keyword(s):  
Chronic Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Older Patients ◽  
Low Dose ◽  
Chronic Phase ◽  
Phase 2 ◽  
Multicentre Phase ◽  
Phase 2 Trial

scholarly journals Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial

2015 ◽  
Vol 16 (8) ◽  
pp. 957-966 ◽  
Author(s):  
Julio Garcia-Aguilar ◽  
Oliver S Chow ◽  
David D Smith ◽  
Jorge E Marcet ◽  
Peter A Cataldo ◽  
...  
Keyword(s):  
Rectal Cancer ◽  
Locally Advanced ◽  
Advanced Rectal Cancer ◽  
Locally Advanced Rectal Cancer ◽  
Neoadjuvant Chemoradiation ◽  
Phase 2 ◽  
Multicentre Phase ◽  
Phase 2 Trial

Phase 2 trial of talabostat and docetaxel in patients with stage IIIb/IV NSCLC

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 7120-7120 ◽  
Author(s):  
C. Cunningham ◽  
D. Richards ◽  
R. Salgia ◽  
R. Leonard ◽  
R. Raju ◽  
...  
Keyword(s):  
Stage Iiib ◽  
Phase 2 ◽  
Phase 2 Trial
Sign in / Sign up

Export Citation Format

Share Document